An industry update: the latest developments in therapeutic delivery.

Area of Science:

• Drug Delivery Technologies
• Biotechnology Industry Trends
• Medical Device Innovation

Background:

• January 2017 industry update sourced from press releases, regulatory filings, and scientific literature.
• New year brings operational plans, reports, and outlooks for the drug delivery sector.
• Financing deals and contract manufacturer showcases highlight industry activity.

Purpose of the Study:

• To provide a comprehensive industry update for drug delivery and related fields in January 2017.
• To highlight key developments in drug delivery, financing, regulatory guidelines, and emerging technologies.
• To forecast future trends and advancements in the biotechnology and medical device sectors.

Main Methods:

• Information gathering from company press releases.
• Analysis of data from regulatory and patent agencies.
• Review of scientific literature publications.

Main Results:

• Publication of market forecasts for various drug delivery spaces.
• Successful financing rounds for companies like Ossianix and Ocular Therapeutix.
• Release of draft FDA guidelines for combination products.
• Advancements in artificial pancreas technology, nanotechnology, and gene therapy.
• Progress in implantable, closed-loop delivery systems nearing clinical success.

Conclusions:

• The drug delivery landscape is dynamic, with significant investment and regulatory focus.
• Emerging technologies such as nanotechnology, gene therapy, and advanced artificial pancreas systems are progressing rapidly.
• The integration of advanced delivery systems promises improved patient outcomes and accessibility in the near future.